Back
HFA Premium Access

EMPEROR-Preserved: association of echocardiographic features of diastolic dysfunction with the clinical efficacy of empagliflozin in HFpEF

Session: Clinical trials updates in medical therapy
Topic: Pharmacotherapy
Speaker: Professor A. Stewart Coats (Sydney, AU)
Event: Heart Failure 2025

Congress Presentation

Add to my library

Like

About the speaker

Professor Andrew Stewart Coats

Heart Research Institute, Sydney (Australia)
113 presentations
23 followers

6 more presentations in this session

Discussant panel

Access
Like
Thumbnail

Effects of finerenone on readmissions for heart failure: a prespecified secondary analysis of the FINEARTS-HF trial

Speaker: Doctor A. Bhatt (San Francisco, US)

Access
Slides
Video
Like
Thumbnail

Trade-off of risk and benefit of finerenone across the spectrum of kidney function in patients with heart failure with mildly reduced and preserved ejection fraction in the FINEARTS-HF trial

Speaker: Doctor S. Chatur (Boston, US)

Access
Slides
Video
Like
Thumbnail

Intravenous ferric carboxymaltose in heart failure with iron deficiency

Speaker: Doctor M. Karakas (Hamburg, DE)

Access
Slides
Video
Like
Thumbnail

Efficacy of intravenous iron for the treatment of heart failure varies by method of meta-analysis: a Bayesian and frequentist reappraisal of the evidence

Speaker: Doctor A. Henderson (Glasgow, GB)

Access
Slides
Video
Like
Thumbnail

Access the full session

Clinical trials updates in medical therapy

Speakers: Professor A. Stewart Coats, Doctor A. Bhatt, Doctor S. Chatur, Doctor M. Karakas, Doctor A. Henderson
Access
Video
Like
Thumbnail

About the event

Image

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources